APLS icon

Apellis Pharmaceuticals

209 hedge funds and large institutions have $4.13B invested in Apellis Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 99 increasing their positions, 53 reducing their positions, and 31 closing their positions.

Holders
209
Holders Change
-1
Holders Change %
-0.48%
% of All Funds
3.53%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.15%
New
34
Increased
99
Reduced
53
Closed
31
Calls
$55.6M
Puts
$22.3M
Net Calls
+$33.3M
Net Calls Change
+$34M
Name Market Value Shares Shares
Change
Shares
Change %
CSS
226
Cubist Systematic Strategies
Connecticut
-10,304 Closed
WG
227
Winton Group
United Kingdom
-9,931 Closed
MF
228
Magnetar Financial
Illinois
-9,532 Closed
MML Investors Services
229
MML Investors Services
Massachusetts
-7,892 Closed
XT
230
XTX Topco
Cayman Islands
-5,422 Closed
SIM
231
Sandia Investment Management
Massachusetts
-5,000 Closed
YIH
232
Y-Intercept (HK)
Hong Kong
-4,363 Closed
PHK
233
Point72 Hong Kong
Hong Kong
-4,181 Closed
CL
234
CSS LLC
Illinois
-1,446 Closed
Walleye Trading
235
Walleye Trading
New York
-518 Closed
FFWM
236
Future Financial Wealth Management
Ohio
-500 Closed
T
237
TCWP
Ohio
-31 Closed
FCA
238
FinTrust Capital Advisors
South Carolina
-5 Closed
PVI
239
Pura Vida Investments
New York
Wolverine Trading
240
Wolverine Trading
Illinois
Nomura Asset Management
241
Nomura Asset Management
Japan
KCM
242
Kingdon Capital Management
New York
CM
243
Caption Management
Oklahoma
CFGS
244
Concourse Financial Group Securities
Alabama
CAL
245
Capital Advisors Ltd
Ohio
$0 8 +8 New
HGWM
246
Harvest Group Wealth Management
Massachusetts
$0 8 +8 New